Cita APA

Kelly, R. J., Thomas, A., Rajan, A., Chun, G., Lopez-Chavez, A., Szabo, E., . . . Giaccone, G. (2013). A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer. Oxford University Press.

Chicago Style Citation

Kelly, R. J., et al. A Phase I/II Study of Sepantronium Bromide (YM155, Survivin Suppressor) With Paclitaxel and Carboplatin in Patients With Advanced Non-small-cell Lung Cancer. Oxford University Press, 2013.

Cita MLA

Kelly, R. J., et al. A Phase I/II Study of Sepantronium Bromide (YM155, Survivin Suppressor) With Paclitaxel and Carboplatin in Patients With Advanced Non-small-cell Lung Cancer. Oxford University Press, 2013.